Home Symetis

Symetis

acquired
Equity Financing
Minimally Invasive Heart Valve Replacement Therapy Developer

Basic Information

Symetis is a Swiss company that develops minimally invasive heart valve replacement therapies for patients with heart valve disease, focusing on the minimally invasive transcatheter aortic valve implantation (TAVI) device market.
Symetis SA
Vaud,Switzerland
51~100 people
January 01, 2001
info@symetis.com